Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00608933 · ClinicalTrials.gov registry record · Phase 3
Education Intervention in Encouraging Health Providers to Talk With Cancer Patients About the Use of Complementary and Alternative Medicine
A Phase 3 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,356
- Enrollment target
NCT00608933: Completed Phase 3 study, sponsored by M.D. Anderson Cancer Center.
NCT00608933 is a Phase 3 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,356 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (76% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00608933, a Phase 3 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,356 participants
- Enrollment target
Study Summary
RATIONALE: Educating health providers on talking with cancer patients about complementary and alternative medicine (CAM) may help encourage health providers to talk more often with cancer patients about the use of CAM. PURPOSE: This randomized phase III trial is studying how well an education intervention works in encouraging health providers to talk with cancer patients about the use of CAM.
Primary Outcome
The Complementary and Alternative Medicine Patient Survey administered to patients to assess personal use of CAM before and after the cancer diagnosis as well as the level of interaction with providers regarding CAM use. Baseline survey assessment at one week and follow up assessment at 2 months.
Interventions
- OTHER questionnaire administration
- OTHER educational intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,356 participants |
| Start Date | 2008-06 |
| Est. Completion | 2020-12-07 |
| Phase | Phase 3 |
What the finished NCT00608933 record still lists
NCT00608933 is an interventional study that assigns participants to a tested intervention. Its 1,356 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (76% higher).
The record links to 0 conditions, and to 2 interventions - of which questionnaire administration is the first listed.
NCT00608933 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00608933 about?
NCT00608933 is a clinical study titled "Education Intervention in Encouraging Health Providers to Talk With Cancer Patients About the Use of Complementary and Alternative Medicine". RATIONALE: Educating health providers on talking with cancer patients about complementary and alternative medicine (CAM) may help encourage health providers to talk more often with cancer patients about the use of CAM. PURPOSE: This randomized phase III trial is studying how well an education inter...
What is the current status of trial NCT00608933?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,356 participants. The study started on 2008-06. Estimated completion is 2020-12-07.
What interventions are being tested in trial NCT00608933?
The interventions under investigation include: questionnaire administration (OTHER), educational intervention (OTHER).
Who is sponsoring clinical trial NCT00608933?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00608933's enrollment target sits among peer trials
1,356 181st of 2000 higher than 1,820 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05245227 · 1,358 participants · Phase 3
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
- NCT06318169 · 1,350 participants · Phase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- NCT06605404 · 1,350 participants
Pan-tumor MRD Study
- NCT06806163 · 1,350 participants · NA
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia